Lexaria Bioscience's total assets for Q3 2025 were $6.74M, a decrease of -22.31% from the previous quarter. LEXX total liabilities were $1.57M for the fiscal quarter, a -17.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.